Forbion holds final close of Forbion Growth Opportunities Fund I at EUR360m
Forbion, a European life sciences venture capital firm, has held the final close of the Forbion Growth Opportunities Fund I (Forbion Growth I) at its hard cap amount of EUR360 million (USD428 million). Forbion Growth I is focused on investing in late-stage European life sciences companies. Pantheon, Eli Lilly and
